Home » Events & Exhibit » 2005 » G8 and Microbicides
G8 and Microbicides
For the first time in G8 history, in 2005 the G8 recognised the urgent need to develop a safe and effective microbicide.
Specifically, the G8 Gleneagles Africa statement states: “(e) Building on the valuable G8 Global HIV/AIDS vaccine enterprise, increasing direct investment and taking forward work on market incentives, as a complement to basic research, through such mechanisms as Public Private Partnerships and Advance Purchase Commitments to encourage the development of vaccines, microbicides and drugs for AIDS, malaria, tuberculosis and other neglected diseases. We note continuing work to explore establishing an International Centre for Genetic Engineering & Biotechnology centre in Africa to help research into vaccines for the diseases that are afflicting the continent.” 
View the full statement here.
On 9 July, the African Microbicide Advocacy Group, the Alliance for Microbicide Development, the Global Campaign for Microbicides, and the International Partnership for Microbicides released press statements in Canada, France, Germany, UK and US announcing the G8’s recognition of microbicides.
“Today’s announcement from the G8 is an important step forward for the world’s women, who desperately need a method of HIV prevention that they can initiate, rather than rely on men’s willingness to be faithful or to use condoms,” said Lori Heise, Director of the Global Campaign for Microbicides.
Manju Chatani, the Coordinator of the African Microbicides Advocacy Group, added, “We believe a microbicide will provide a powerful new option for African women to protect themselves. We encourage the G8 to also support efforts towards preparing for future access to effective microbicides, now.”
Get basic information about the G8
Download press releases in French and English here:
|
Canada |
||
|
France |
||
|
Germany |
||
|
UK |
||
|
US |
